Covered recipient · General Payments record
STEFANIE MAIRE MOELLER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$1,232.81
- Reported across 79 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $333.24 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $106.78 | 5 |
| Acerta Pharma LLC | $91.50 | 4 |
| Novo Nordisk AS | $52.45 | 3 |
| PFIZER INC. | $30.25 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.35 | 1 |
| ABBVIE INC. | $17.41 | 1 |
| DEXCOM, INC. | $14.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.41 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203105165 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.41 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206599046 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.06 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206526752 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.62 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207243929 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.41 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206440918 | CMS |
| Dexcom, Inc. | $14.50 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250528603 | CMS |
| Lilly USA, LLC | $22.35 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186854015 | CMS |
| Lilly USA, LLC | $14.16 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186940521 | CMS |
| Lilly USA, LLC | $20.59 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186893189 | CMS |
| Lilly USA, LLC | $25.34 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186904636 | CMS |
| Lilly USA, LLC | $24.34 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186940523 | CMS |
| Novartis Pharmaceuticals Corporation | $20.35 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200773919 | CMS |
| Novo Nordisk Inc | $19.94 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188553105 | CMS |
| Novo Nordisk Inc | $17.86 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188430701 | CMS |
| Novo Nordisk Inc | $14.65 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189035832 | CMS |
| PFIZER INC. | $15.06 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230116012 | CMS |
| PFIZER INC. | $15.19 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230683276 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.